Fundraising Fox
Alexion Pharmaceuticals
Boston, US · 3 known investors
Find your way into Alexion Pharmaceuticals
Sign up to find every way you can get introduced to Alexion Pharmaceuticals
- Your email: who you already know at Alexion Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Alexion Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Alexion is a biopharmaceutical company focused on research and development of treatments for rare diseases, serving rare disease patients and their families worldwide.
Investors · 3
Founder mafia
The Alexion Pharmaceuticals mafia →7 people who came through Alexion Pharmaceuticals went on to found or lead other companies.
Romesh SubramanianSenior Director - Discovery ResearchFounded RaNA Therapeutics +2Abbie CelnikerSVP, Translational MedicineFounded Eleven BiotherapeuticsBrian GoffChief Commercial and Global Operations OfficerFounded Agios PharmaceuticalsSusan HillSenior Director, Global Business & Corporate DevelopmentFounded MestagHENRIC BJARKEVP North America Commercial OperationsFounded Tenpoint TherapeuticsSaqib IslamExecutive Vice President - Chief Strategy OfficerFounded Beeline MedicinesRandy TeelExecutive Director, Strategic Enterprise Risk ManagementFounded Arvinas Holding Co. LLC
Related companies · 4
AlumniAstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Regeneron NASDAQ: REGN www.regeneron.comRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Companies working in the same space as Alexion Pharmaceuticals.
Acquisitions · 2
Early investors' stakes continue via these dealsSynageva BioPharma Corp.
Developed therapies for rare conditions with unmet medical needs; exited via IPO and acquired by Alexion Pharmaceuticals.
Syntimmune
Acquired by Alexion Pharmaceuticals
Frequently asked questions
- What does Alexion Pharmaceuticals do?
- Alexion is a biopharmaceutical company focused on research and development of treatments for rare diseases, serving rare disease patients and their families worldwide.
- Who are Alexion Pharmaceuticals's investors?
- Alexion Pharmaceuticals's investors include Andera Partners, Connecticut Innovations, venBio Partners.
- Where is Alexion Pharmaceuticals headquartered?
- Alexion Pharmaceuticals is headquartered in Boston, US.